compositions comprising a d2 dopaminergic receptor inhibitor as well as the use of the preferred inhibitor

摘要

compositions and methods for treating parkinson's disease. This invention describes receptor inhibitor compositions, including typical antipsychotic agents, for example haloperidol, and methods of use for treating cylindrical signs or symptoms of parkinson's disease. In addition, this invention describes compositions and methods of inducing supersensitivity in dopamine d2 and other receptors involved in prakinson disease as a means of alleviating the clinical signs or symptoms of parkinson's disease.